Clinical trials
Blood Coagulation Disorders trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Swedish Orphan Biovitrum | 4 |
| Bayer | 2 |
| BioMarin Pharmaceutical | 2 |
| Genzyme, a Sanofi Company | 2 |
| European Society of Anaesthesiology | 1 |
| Hutchmed | 1 |
| Kedrion S.p.A. | 1 |
| Novartis Pharmaceuticals | 1 |
| Sierra Oncology LLC - a GSK company | 1 |
| Spur Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blood Coagulation Disorders | 18 |
| Hematologic Diseases | 11 |
| Hemophilia A | 9 |
| Hemorrhagic Disorders | 9 |
| Coagulation Protein Disorders | 8 |
| Blood Coagulation Disorders, Inherited | 5 |
| Genetic Diseases, Inborn | 5 |
| Hemophilia B | 4 |
| Blood Platelet Disorders | 3 |
| Autoimmune Diseases | 2 |
Trials
Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.